320 related articles for article (PubMed ID: 18300116)
1. Frequency and clinical profile of patients with polycystic kidney disease in southern Brazil.
Nunes AC; Milani V; Porsch DB; Rossato LB; Mattos CB; Roisenberg I; Barros EJ
Ren Fail; 2008; 30(2):169-73. PubMed ID: 18300116
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor polymorphism and autosomal dominant polycystic kidney disease.
Magistroni R; Manfredini P; Furci L; Ligabue G; Martino C; Leonelli M; Scapoli C; Albertazzi A
J Nephrol; 2003; 16(1):110-5. PubMed ID: 12653106
[TBL] [Abstract][Full Text] [Related]
3. Complications of autosomal dominant polycystic kidney disease in 50 haemodialysed patients. A case-control study. The U.C.L. Collaborative Group.
Christophe JL; van Ypersele de Strihou C; Pirson Y
Nephrol Dial Transplant; 1996 Jul; 11(7):1271-6. PubMed ID: 8672022
[TBL] [Abstract][Full Text] [Related]
4. Influence of ACE (I/D) and G460W polymorphism of alpha-adducin in autosomal dominant polycystic kidney disease.
Persu A; El-Khattabi O; Messiaen T; Pirson Y; Chauveau D; Devuyst O
Nephrol Dial Transplant; 2003 Oct; 18(10):2032-8. PubMed ID: 13679477
[TBL] [Abstract][Full Text] [Related]
5. [Autosomal dominant polycystic kidney disease (ADPKD). in Morocco. Multicenter study about 308 families].
Bourquia A;
Nephrologie; 2002; 23(2):93-6. PubMed ID: 12012754
[TBL] [Abstract][Full Text] [Related]
6. Abdominal wall hernia in autosomal dominant polycystic kidney disease.
Morris-Stiff G; Coles G; Moore R; Jurewicz A; Lord R
Br J Surg; 1997 May; 84(5):615-7. PubMed ID: 9171744
[TBL] [Abstract][Full Text] [Related]
7. [Epidemiological and molecular study of autosomal dominant polycystic kidney disease (ADPKD) in the province of Vicenza, Italy: possible founder effect?].
Corradi V; Gastaldon F; Virzi' GM; Clementi M; Nalesso F; Cruz DN; de Cal M; Torregrossa R; Ronco C
G Ital Nefrol; 2010; 27(6):655-63. PubMed ID: 21132648
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of hypertension in young adults with autosomal dominant polycystic kidney disease compared with the general U.S. population.
Kelleher CL; McFann KK; Johnson AM; Schrier RW
Am J Hypertens; 2004 Nov; 17(11 Pt 1):1029-34. PubMed ID: 15533729
[TBL] [Abstract][Full Text] [Related]
9. [Epidemiologic data, clinical and prognostic features of autosomal dominant polycystic kidney disease in a French region].
Simon P; Le Goff JY; Ang KS; Charasse C; Le Cacheux P; Cam G
Nephrologie; 1996; 17(2):123-30. PubMed ID: 8838759
[TBL] [Abstract][Full Text] [Related]
10. Incidence of chronic kidney disease in India.
Dash SC; Agarwal SK
Nephrol Dial Transplant; 2006 Jan; 21(1):232-3. PubMed ID: 16221717
[No Abstract] [Full Text] [Related]
11. A promoter polymorphism of the alpha 8 integrin gene and the progression of autosomal-dominant polycystic kidney disease.
Zeltner R; Hilgers KF; Schmieder RE; Porst M; Schulze BD; Hartner A
Nephron Clin Pract; 2008; 108(3):c169-75. PubMed ID: 18277079
[TBL] [Abstract][Full Text] [Related]
12. Hypertension awareness, treatment, and control in chronic kidney disease.
Sarafidis PA; Li S; Chen SC; Collins AJ; Brown WW; Klag MJ; Bakris GL
Am J Med; 2008 Apr; 121(4):332-40. PubMed ID: 18374693
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of colonic diverticular disease in autosomal dominant polycystic kidney disease without end-stage renal disease.
Sharp CK; Zeligman BE; Johnson AM; Duley I; Gabow PA
Am J Kidney Dis; 1999 Nov; 34(5):863-8. PubMed ID: 10561142
[TBL] [Abstract][Full Text] [Related]
14. Management of ESRD in patients with autosomal dominant polycystic kidney disease.
Alam A; Perrone RD
Adv Chronic Kidney Dis; 2010 Mar; 17(2):164-72. PubMed ID: 20219619
[TBL] [Abstract][Full Text] [Related]
15. Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation.
Pietrzak-Nowacka M; Safranow K; Dziewanowski K; Debska-Slizień A; Głyda M; Gołembiewska E; Jankowska M; Nowosiad M; Rutkowski B; Ciechanowski K
Ann Acad Med Stetin; 2008; 54(1):41-8. PubMed ID: 19127808
[TBL] [Abstract][Full Text] [Related]
16. Sleep disorders in patients with end-stage renal disease undergoing dialysis therapy.
Merlino G; Piani A; Dolso P; Adorati M; Cancelli I; Valente M; Gigli GL
Nephrol Dial Transplant; 2006 Jan; 21(1):184-90. PubMed ID: 16144846
[TBL] [Abstract][Full Text] [Related]
17. Survival after end-stage renal disease in autosomal dominant polycystic kidney disease: contribution of extrarenal complications to mortality.
Perrone RD; Ruthazer R; Terrin NC
Am J Kidney Dis; 2001 Oct; 38(4):777-84. PubMed ID: 11576881
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of vancomycin-resistant enterococci colonization and its risk factors in chronic hemodialysis patients in Shiraz, Iran.
Assadian O; Askarian M; Stadler M; Shaghaghian S
BMC Infect Dis; 2007 Jun; 7():52. PubMed ID: 17553129
[TBL] [Abstract][Full Text] [Related]
19. Outcome of kidney transplantation in patients with polycystic kidney disease: a single center study.
Roozbeh J; Razmkon AR; Jalaeian H; Raiss-Jalali GA; Behzadi S; Sagheb MM; Salahi H; Bahador A; Nikeghbalian S; Davari HR; Salehipour M; Malek-Hosseini SA
Saudi J Kidney Dis Transpl; 2008 Jan; 19(1):72-5. PubMed ID: 18087127
[TBL] [Abstract][Full Text] [Related]
20. Polycystic liver: clinical characteristics of patients with isolated polycystic liver disease compared with patients with polycystic liver and autosomal dominant polycystic kidney disease.
Hoevenaren IA; Wester R; Schrier RW; McFann K; Doctor RB; Drenth JP; Everson GT
Liver Int; 2008 Feb; 28(2):264-70. PubMed ID: 17927714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
